Chen C, Wang C, Hu C, Han Y, Zhao L, Zhu X, et al. Normoalbuminuric diabetic kidney disease. Front Med. 2017;11(3):310–8.
Jiang W, Wang J, Shen X, Lu W, Wang Y, Li W, et al. Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts. Diabetes Care. 2020;43(4):925–33.
American Diabetes A. 11. Microvascular complications and foot care: standards of medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S124–38.
The Microvascular Complications Group of Chinese Diabetes A. Chinese clinical practice guideline of diabetic kidney disease. Chinese J Diab Mellitus. 2019;11(1):15–28.
Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with Diabetes, 1988-2014. JAMA. 2016;316(6):602–10.
Klimontov VV, Korbut AI. Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes. Diabetol Metab Syndr. 2019;13(1):474–9.
Gong W, He M, Yu Y, Wang M, Yang Y, Sun F, et al. Clinical features and risk factors of normoalbuminuric chronic kidney disease in hospitalized patients with type 2 diabetes mellitus. Chinese J Diab Mellitus. 2018;10(4):269–73.
Du R, Zhang Y, Li Q, Li L. Clinical features of normoalbuminuric diabetic kidney disease in patients with type 2 diabetes. Chinese J Diab Mellitus. 2017;9(8):494–8.
An JH, Cho YM, Yu HG, Jang HC, Park KS, Kim SY, et al. The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. J Korean Med Sci. 2009;24(Suppl):S75–81.
Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complicat. 2013;27(2):123–7.
Weil EJ, Fufaa G, Jones LI, Lovato T, Lemley KV, Hanson RL, et al. Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 Diabetes. Diabetes. 2013;62(9):3224–31.
Kose E, An T, Kikkawa A, Matsumoto Y, Hayashi H. The association between the increase in pulse pressure and renal function in chronic kidney disease patients with dyslipidemia. Pharmazie. 2016;71(9):510–3.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.
Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.
Liu LS. Writing Group of Chinese Guidelines for the Management of H: [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.
Zureik M, Bureau JM, Temmar M, Adamopoulos C, Courbon D, Bean K, et al. Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension. 2003;41(3):519–27.
Choi KH, Park TK, Kim J, Ko YG, Yu CW, Yoon CH, et al. Sex differences in outcomes following endovascular treatment for symptomatic peripheral artery disease: An analysis from the K- VIS ELLA registry. J Am Heart Assoc. 2019;8(2):e010849.
Red Blood Cell Diseases Group CSoHCMA. Chinese expert consensus on the application of intravenous iron (2019). Zhonghua Xue Ye Xue Za Zhi. 2019;40(5):358–62.
Clase CM, Barzilay J, Gao P, Smyth A, Schmieder RE, Tobe S, et al. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes. Kidney Int. 2017;91(3):683–90.
Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA, Hillege HJL, et al. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int. 2011;80(3):282–7.
Weir MR. Acute changes in glomerular filtration rate with renin-angiotensin system (RAS) inhibition: clinical implications. Kidney Int. 2017;91(3):529–31.
Wang Z, do Carmo JM, da Silva AA, Fu Y, Hall JE. Mechanisms of synergistic interactions of diabetes and hypertension in chronic kidney disease: role of mitochondrial dysfunction and er stress. Curr Hypertens Rep. 2020;22(2):15.
Peralta CA, Jacobs DR Jr, Katz R, Ix JH, Madero M, Duprez DA, et al. Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis. 2012;59(1):41–9.
Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(10):918–29.
Wang Y, Hu Y, Li Y, Li H, Chu S, Zhu D, et al. Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients. Hypertens Res. 2012;35(2):201–6.
Glassock R, Delanaye P, El Nahas M. An age-calibrated classification of chronic kidney disease. Jama. 2015;314:6.
O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758–65.
Murussi M, Gross JL, Silveiro SP. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric type 2 diabetic patients and normal individuals. J Diabetes Complicat. 2006;20(4):210–5.
Bloomgarden Z, Handelsman Y. How does CKD affect HbA1c? J Diabetes. 2018;10(4):270.
Sinha N, Mishra TK, Singh T, Gupta N. Effect of iron deficiency anemia on hemoglobin A1c levels. Ann Lab Med. 2012;32(1):17–22.
Hannedouche T, Fouque D, Joly D. Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia. Nephrologie Ther. 2018;14(6):6S17–16S25.
Gan T, Liu X, Xu G. Glycated albumin versus HbA1c in the evaluation of glycemic control in patients with Diabetes and CKD. Kidney Int Rep. 2018;3(3):542–54.
Kim IY, Kim MJ, Lee DW, Lee SB, Rhee H, Song SH, et al. Glycated albumin is a more accurate glycaemic indicator than haemoglobin A1cin diabetic patients with pre-dialysis chronic kidney disease. Nephrology. 2015;20(10):715–20.
Lee CL, Li TC, Lin SY, Wang JS, Lee IT, Tseng LN, et al. Dynamic and dual effects of glycated hemoglobin on estimated glomerular filtration rate in type 2 diabetic outpatients. Am J Nephrol. 2013;38(1):19–26.
Remuzzi A, Viberti G, Ruggenenti P, Battaglia C, Pagni R, Remuzzi G. Glomerular response to hyperglycemia in human diabetic nephropathy. Am J Phys. 1990;259(4 Pt 2):F545–52.
Wei F, Chang B, Yang X, Wang Y, Chen L, Li WD. Serum uric acid levels were dynamically coupled with hemoglobin A1c in the development of type 2 Diabetes. Sci Rep. 2016;6:28549.
Chang Y-H, Lei C-C, Lin K-C, Chang D-M, Hsieh C-H, Lee Y-J. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study. Diabetes Metab Res Rev. 2016;32(6):557–64.
Tanaka K, Hara S, Hattori M, Sakai K, Onishi Y, Yoshida Y, et al. Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes. J Diabetes Investig. 2015;6(1):98–104.
Seo DH, Kim SH, Song JH, Hong S, Suh YJ, Ahn SH, et al. Presence of carotid plaque is associated with rapid renal function decline in patients with type 2 Diabetes mellitus and Normal renal function. Diabetes Metab J. 2019;43(6):840–53.
Roumeliotis A, Roumeliotis S, Panagoutsos S, Theodoridis M, Argyriou C, Tavridou A, et al. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease. Ren Fail. 2019;41(1):131–8.
Wu Z, Wang X, Jia J, Li Y, Jiang Y, Li J, et al. Kidney function predicts the risk of asymptomatic peripheral arterial disease in a Chinese community-based population. Int Urol Nephrol. 2020;52(3):525–32.
Zhao W, Wang Y, Shuai Y, Wang N, Zhang J, Zhang Y, et al. Correlation between microalbuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Chinese J Diab Mellitus. 2018;10(8):542–7.
Liyanage P, Lekamwasam S, Weerarathna TP, Srikantha D. Prevalence of normoalbuminuric renal insufficiency and associated clinical factors in adult onset diabetes. BMC Nephrol. 2018;19(1):200.
Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, et al. Renal structure in Normoalbuminuric and Albuminuric patients with type 2 Diabetes and impaired renal function. Diabetes Care. 2013;36(11):3620–6.